—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Waters Corporation (WAT) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for WAT, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.97 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How WAT has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.97 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Waters Corporation moved 0.97% on average · correlation 0.25 · higher than 85% of US names
  • Beta, last 3 months 0.98 about the same as over the year
  • On the 10 worst bond days −0.36% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +2.31% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against WAT on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Waters Corporation

WAT in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Waters makes liquid chromatography and mass spectrometry instruments that separate and identify compounds in a sample, along with the columns and consumables those instruments use up. It also sells thermal analysis, rheometry and calorimetry tools that test how materials behave under heat and stress, plus software that runs its own and other makers' instruments. Customers span pharmaceutical, clinical, industrial and academic laboratories that need to verify what a substance contains or how stable it is. It is based in Milford, Massachusetts.
Where it sits in the stack
Waters carries no seat in our index, so it sits in the Healthcare sector of our universe, in the diagnostics-and-research sleeve rather than the AI build-out stack. Its instruments serve drug discovery and quality-control labs, a demand line tied to pharmaceutical and biotech research budgets rather than to compute or chip capacity.
Who it is priced against
Our diary has not set a peer group for this name; the comparison the market draws is with Agilent Technologies, another maker of laboratory analytical instruments.
Why Closelooknet tracks it
It is an S&P 500 constituent; it does not yet carry a Closelooknet score and has not been quoted in our editions.
What the diary watches
Whether pharmaceutical and biotech research spending, which drives instrument and consumable orders, holds up or slows as lab budgets are set.

Waters Corporation (WAT) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by Goldman Sachs, 2026-09-21

The Street on this name

Analyst actions and the latest print for WAT from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Goldman Sachs — target 515 from 465 Target raised to $515 from $465 (+22.1% to spot) 2026-09-21

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Waters Corporation (WAT)?

Waters Corporation trades as WAT on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is WAT in a Closelooknet index?

Not currently — Waters Corporation is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does WAT trade against its moving averages?

Uptrend stack intact: Trades +7.4% vs the 50-day and +19.6% vs the 200-day average, 0.6% below the 52-week high and +53.3% off the 52-week low; a golden cross printed 61 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Waters Corporation trade when bond yields rise?

Over the past year Waters Corporation had a beta of 0.97 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 85% of US names. On the 10 sessions in which long bonds fell most it moved −0.36% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Waters Corporation do?

Waters makes liquid chromatography and mass spectrometry instruments that separate and identify compounds in a sample, along with the columns and consumables those instruments use up. It also sells thermal analysis, rheometry and calorimetry tools that test how materials behave under heat and stress, plus software that runs its own and other makers' instruments. Customers span pharmaceutical, clinical, industrial and academic laboratories that need to verify what a substance contains or how stable it is. Our diary has not set a peer group for this name; the comparison the market draws is with Agilent Technologies, another maker of laboratory analytical instruments.

Where does Waters Corporation sit in the AI build-out?

Waters carries no seat in our index, so it sits in the Healthcare sector of our universe, in the diagnostics-and-research sleeve rather than the AI build-out stack. Its instruments serve drug discovery and quality-control labs, a demand line tied to pharmaceutical and biotech research budgets rather than to compute or chip capacity. It is an S&P 500 constituent; it does not yet carry a Closelooknet score and has not been quoted in our editions.

What has Wall Street done on Waters Corporation recently?

The most recent analyst action on Waters Corporation on the Closelooknet wire is a price target by Goldman Sachs on 2026-09-21 (target 515 from 465). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for WAT, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.